LYCOPENE AND ATHEROGENIC RISK FACTORS: A REVIEW

*Hassah Batool Iftikhar

ABSTRACT

Coronary heart disease is marked as the third–fourth largest global deaths worldwide by addressing the attributes of high increase hazard ratios across multiple variables: Hypertension, Dyslipidemia, Elevated cholesterol, chronic inflammation and metabolic syndrome expressing the unawareness of risk assessment. Lycopene as a superior carotenoid with antiatherogenic effect can be used consequently in preventions of long term cardiovascular risk reduction strategies. Clinical trials on animals and human studies indicate the antioxidant property in lycopene is beneficial on carotid plaques and aortic intima media thickness in vivo by stabilizing the effectiveness on extraneous factors in behaving equally to statin drugs but act alternatively natural reflex adjuvant therapy. The present review article support the therapeutic efficacy about lycopene in reducing coronary events significantly with respect to its protective role in cardiovascular health.

Keywords: Lycopene, Carotenoid, Antioxidant, Coronary heart disease, Risk factors, Safety.